TransferGWAS of T1-weighted Brain MRI Data from the UK Biobank - Rakowski, Alexander; Monti, Remo; Lippert, Christoph (medRxiv, 2024)
Genome-wide association studies (GWAS) traditionally analyze single traits, e.g., disease diagnoses or biomarkers. Nowadays, large-scale cohorts such as the UK Biobank (UKB) collect imaging data with sample sizes large enough to perform genetic association testing. Typical approaches to GWAS on high-dimensional modalities extract predefined features from the data, e.g., volumes of regions of interest. This limits the scope of such studies to predefined traits and can ignore novel patterns present in the data. TransferGWAS employs deep neural networks (DNNs) to extract low-dimensional representations of imaging data for GWAS, eliminating the need for predefined biomarkers. Here, we apply transferGWAS on brain MRI data from the UKB. We encoded 36, 311 T1-weighted brain magnetic resonance imaging (MRI) scans using DNN models trained on MRI scans from the Alzheimer’s Disease Neuroimaging Initiative, and on natural images from the ImageNet dataset, and performed a multivariate GWAS on the resulting features. Furthermore, we fitted polygenic scores (PGS) of the deep features and computed genetic correlations between them and a range of selected phenotypes. We identified 289 independent loci, associated mostly with bone density, brain, or cardiovascular traits, and 14 regions having no previously reported associations. We evaluated the PGS in a multi-PGS setting, improving predictions of several traits. By examining clusters of genetic correlations, we found novel links between diffusion MRI traits and type 2 diabetes.Author Summary Genome-wide association studies are a popular framework for identifying regions in the genome influencing a trait of interest. At the same time, the growing sample sizes of medical imaging datasets allow for their incorporation into such studies. However, due to high dimensionalities of imaging modalities, association testing cannot be performed directly on the raw data. Instead, one would extract a set of measurements from the images, typically using predefined algorithms, which has several drawbacks - it requires specialized software, which might not be available for new or less popular modalities, and can ignore features in the data, if they have not yet been defined. An alternative approach is to extract the features using pretrained deep neural network models, which are well suited for complex high-dimensional data and have the potential to uncover patterns not easily discoverable by manual human analysis. Here, we extracted deep feature representations of brain MRI scans from the UK Biobank, and performed a genome-wide association study on them. Besides identifying genetic regions with previously reported associations with brain phenotypes, we found novel regions, as well as ones related to several other traits such as bone mineral density or cardiovascular traits.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research has received funding by the European Commission in the Horizon 2020 project INTERVENE (Grant agreement ID: 101016775), and was partially funded by the HPI Research School on Data Science and Engineering.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:We used only data for the UK Biobank and the Alzheimer's Disease Neuroimaging Initiative, both of which were available publicly before our studyI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesData produced are available as supplementary material (PheWAS summary statistics and genetic correlation results) and at figshare (GWAS summary statistics and polygenic scores weights) https://doi.org/10.6084/m9.figshare.25933717.v1 https://doi.org/10.6084/m9.figshare.25933663.v1 https://github.com/HealthML/transfer-gwas-brain-mri